GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...

GSK's regulatory filing for expanded use of RSV vaccine, Arexvy, in adults aged 18 years and older has been accepted for ...

James Moss, the director of cyber investigations at law firm Addleshaw Goddard, told Sky News the ICO's fine was "about as ...

GSK PLC closed 11.51% short of its 52-week high of £16.79, which the company achieved on September 9th.

Phase 2 trial results support Isa-KRd as a standard treatment option for patients with high-risk, newly diagnosed multiple myeloma, according to researchers.

An asthma drug biotech that was acquired in a deal with GSK plc worth up to $1.4 billion is now at the center of a lawsuit, ...

Nagpur: Tragedy struck a pharma company's unit in Nagpur district on Tuesday when a blast occurred in a glass line reactor, ...

Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds ...

These findings are very important for patients with early-stage dMMR tumors because it’s likely they do not need surgery or radiation if they are treated first with immunotherapy for a sufficient ...

The Information Commissioner's Office (ICO) has fined genetic testing company 23andMe £2.31m for failing to implement appropriate security measures to protect the ...

Twin pipelines will carry liquefied petroleum gas from the country's largest oilfield for conversion into polymers ...